Phase I trials in clinical oncostatic pharmacology.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation / Q000592:standards*; D004994:Ethics, Pharmacy; D000882:Haplorhini; D006801:Humans; D051379:Mice; D010601:Pharmacology, Clinical / Q000379:methods*; D012107:Research Design
D000970:Antineoplastic Agents